Good News: The Federal Government Just Made It a Whole Lot Easier to Access Opioid Addiction Treatment

No more daily trips to the methadone clinic.

Boston Globe/Getty

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

For the hundreds of thousands of Americans who have to visit clinics for daily doses of opioid addiction medication, social distancing is nearly impossible. But on Tuesday, the federal government eased some of its long-held restrictions in response to the coronavirus.

That’s good news, because continual access to two primary treatment medications, buprenorphine and methadone, is key: If patients miss a dose, they could go into withdrawal and turn to street drugs, risking overdose.

Those struggling with addiction are particularly vulnerable in the age of coronavirus for a host of reasons. Opioid users have far higher rates of health conditions including hepatitis C, HIV, and chronic bronchitis. Many are well over the age of 60. Infectious disease can spread like wildfire among communities of drug users (think the HIV outbreak in Indiana in 2015). And then there are the psychological factors: “We all know that stress is one of the major triggers for people to go into relapse,” said Bethany Hallam, an Allegheny County councilwoman and outspoken addiction treatment advocate. “To think of all the additional stressors that people have in their lives right now, on top of the regular every day stressors—and then you add into that people sitting at home stewing.”

As Corey Davis, an attorney at the Network for Public Health Law, put it, “We’re now facing two deadly, concurrent declared public health emergencies: the opioid crisis and COVID-19.”

Methadone: Daily Trips to Clinics Will No Longer Be Required

Some 350,000 Americans rely on methadone clinics for daily opioid addiction treatment, and, under normal circumstances, they’re required by law to take their doses at methadone clinics, where they often wait in long lines to take their doses in a supervised setting. 

Federal guidance so far when it comes to methadone clinics during the pandemic has been confusing, to say the least. Until this week, the Substance Abuse and Mental Health Administration’s directed clinics to follow each state’s lead on a coronavirus response. On Monday, SAMHSA released two conflicting sets of guidelines for methadone clinics and patients. The first permitted a take-home supply of up to two weeks, but only if a methadone patient had coronavirus or symptoms of it, got a clinician to sign off, and applied with that sign-off to SAMHSA.

But separate guidance, also released Monday by SAMHSA, is much more lax, allowing for four weeks of take-home doses for stable patients—with no state or federal sign-off required for each patient—and two weeks for less-stable patients who the clinic believes “can safely handle this level of take-home medication.” This is the guidance that will hold during the pandemic, says SAMHSA spokesperson Christopher Garrett: Monday’s more restrictive guidelines were taken down this morning.

The coronavirus is putting pressure on an age-old controversy over just how much red tape should exist around opioid addiction treatment. Methadone is among America’s most highly regulated medications, relegated to special clinics rather than accessible at a typical doctor’s office. In theory, that’s because methadone is itself an opioid, but one that is meant to ease the cravings of opioid addiction without getting the patient high. The highly regulated setting is beneficial for some: The idea is that it ensures people aren’t abusing the medication or selling it on the street. But methadone advocates, including many leading public health experts, have long pushed for methadone to be treated just like any other medication: For now, the average doctor is allowed to prescribe a number of addictive opioids like OxyContin, Vicodin, or fentanyl, but isn’t allowed to prescribe methadone, the opioid addiction treatment.

Buprenorphine: In-Person Requirements Will Be Eased

The second primary opioid addiction treatment is buprenorphine, also itself an opioid, also to be taken daily, but treated more like a normal medication: Patients can go to doctors’ offices for their prescriptions and pick up their medications from pharmacies. 

Until Tuesday, one big concern about buprenorphine access was the requirement that providers meet prospective new patients for evaluations in person, rather than using telemedicine for the initial consultations. Given the push for social distancing and the overrun medical system, many feared that this rule would effectively prevent any new patients from being able to start buprenorphine. On Tuesday, DEA eased these restrictions: Now, initial consultations can be done virtually. 

There are still a lot of restrictions around buprenorphine: Providers have to get special licenses from the DEA to prescribe the medication, and once they do, they can only prescribe it to a certain number of patients. Given the pandemic, some are advocating for an ease on the those caps: “We don’t know what proportion of our prescriber population is going to fall ill,” said Greg Marotta, president of Clean Slate, the nation’s largest office-based opioid treatment provider. “For us to have to turn away patients because we don’t have the prescribing capacity available to us would be an absolute disaster.”

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate